// App-Quantinova.ai

: Healthcare Resource Utilization and Costs Associated with AL Amyloidosis: A Retrospective Matched Cohort Study

Researchers

Presenter

  • Hsin-An Hou

Principal Investigators

  • Shih-Pei Shen

  • Kuan-Chih Huang

  • Choo Hua Goh

  • Hong Qiu

  • Lee Anne Rothwell

  • Kwang-We Wu

  • Hitesh Chandwani

  • Yanfang Liu

  • Chao-Hsiun Tang

Medical Centers

  • School of Health Care Administration, Taipei Medical University, Taipei, Taiwan

  • Janssen Market Access Asia Pacific, Singapore, Singapore

  • Janssen Medical Affairs, Singapore, Singapore

  • Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

  • Global Epidemiology, Office of the Chief Medical Officer, Johnson & Johnson, Raritan

  • Janssen Medical Affairs, Macquarie Park, Australia

Locations

  • Taiwan

  • Singapore

  • United States

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • AL Amyloidosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved